India, Oct. 5 -- IPO-bound PharmEasy which is set to file its draft red herring prospectus in this month is likely to bring in a new set of investors such as Steadview Capital, IIFL and a US-hedge fund to raise its pre-IPO round.

As per an ET report, PharmEasy has already finalised a secondary transaction of around $100 Mn where existing investors such as Fundamentum, Eight Road Ventures and Bessemer Venture Partners will be making a partial exit.

The national daily reported that the epharmacy startup PharmEasy is looking to close $300 Mn in its pre-IPO round. If the startup manages to close the round, it's valuation will increase by a billion dollars from existing $4.2 Bn to $5.8 Bn.

API Holdings, the parent company of online pharmacy...